§ 16 AMWHV
Batch release is the responsibility of the Qualified Person under § 14 AMG, who reviews the manufacturing and testing records and conformity with the marketing authorisation.
Case studies · Mid-sized pharmaceutical company and marketing authorisation holder
A marketing authorisation holder needed a partner for batch release and for qualifying its contract manufacturers. We release batches on an ongoing basis and carry out risk-based audits.
At a glance
How it went
Told plainly, in the order it actually happened.
What the client came to us with. A pharmaceutical company holding marketing authorisations was looking for a partner for two tasks: batch release of its commercial, authorised medicinal products and qualification of the contract manufacturers that produce them.
What we actually did. We oversee the GMP-compliant manufacture of the authorised medicinal products and release the batches. We qualify the contract manufacturers through audits.
The outcome. Batches are released on an ongoing basis, and the supply of the medicinal products is secured. Manufacture remains GMP-compliant, and the marketing authorisation holder needs fewer of its own staff for this work.
Terms used in this case
Anonymised. Confidentiality is part of our business; we only name clients with their consent.
The legal framework
Batch release is the responsibility of the Qualified Person under § 14 AMG, who reviews the manufacturing and testing records and conformity with the marketing authorisation.
Before certification, all audits of manufacturing and testing sites and of the active substance manufacturer must be completed and available to the QP; repeat audits follow risk management.
Before outsourcing, the contract giver assesses the legality, suitability and competence of the contract acceptor, sets out duties in a written contract and monitors performance.
In a similar situation?
No ticketing system, no switchboard passing you on. You will hear back within one to two days.
More case studies
Mid-sized company in pharmaceutical research
A highly potent cancer active substance manufactured some time ago is to be used for an investigational medicinal product. We assessed its GMP co...
Read the full case studyClinical trial sponsor, university hospital
A university hospital needed a medicinal product and a placebo for a trial in a new indication. We found the manufacturer, prepared the applicati...
Read the full case studyClinical trial sponsor, small biotech company
The active substance and the investigational medicinal product are manufactured outside the EU. We oversaw GMP-compliant manufacture, audited the...
Read the full case studyCall us or write a few lines. You will reach someone who can assess your request with real expertise.
As a member of the Life Science Nord cluster, we benefit from a strong, innovative network and work with other experts in the industry on forward-looking developments.
As a registered supplier on Scientist.com, we can also be reached through this platform: companies registered there can send their project requests directly to us.